One-Year Follow-up Safety Study in Subjects Previously Implanted With VC-01™

ViaCyte

Status: Completed

Conditions: Type 1 Diabetes Mellitus

Study type: Observational

Funder types: Industry

Identifiers

NCT02939118

VC01-201

Details and patient eligibility

About

The purpose of this trial is to evaluate the long-term safety in subjects previously implanted with VC-01™ combination product.

Enrollment: 51 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Previous implantation of VC-01™ combination product with subsequent explantation of all VC-01 units.

Exclusion criteria

• There are no exclusion criteria for this trial.